Or in dry eye talk, the inflammation or the increased osmolarity?
http://www.theratears.com/documents/dryeyeround.pdf
The link above was posted earlier and it is pretty interesting. A roundtable discussion of scientists at the leading dry-eye pharmaceuticals talking about treatment and causes of dry eye. There is quite a lot of disagreement, most of which centers upon whether inflammation or increased osmolarity comes first in dry eye.
I personally believe that increased osmolarity is essentially a synonym for dry eye. If there are less tears, of course there is going to be a higher concentration of salt in the remaining tears. I don't see how this could be a cause of dry eye. It's a symptom. It's like saying that decreased tear volume is the cause of dry eye.
Therefore, I'm more inclined to believe that inflammation disrupts the neural circuit, damages the lacrimal system, lowers tear volume and therefore increases tear osmolarity. But maybe something else is the root cause, and inflammation is just another symptom. I think it's plain to see after reading this article that we aren't quite as close to discovering the cause of DES as I had hoped we were.
I was also struck by Dr. Gilbard's incessant promotion of TheraTears products. Every other sentence he spoke mentioned them. I used TheraTears drops for several months with no noticeable improvement. In fact, I found myself needing to use the drops more and more often as time went by. But whatever, it didn't work for me, that's fine. What bothers me is that these physicians get so tied in to the success of their products that they begin to ignore other things. Of course, this problem isn't unique to DES, but I think it's more concerning in DES, since there aren't nearly as many physicians out there doing research on it as compared to say cancer or heart disease.
Okay, enough of my Sunday morning philosophizing. I'd be curious to hear what others think about this link.
http://www.theratears.com/documents/dryeyeround.pdf
The link above was posted earlier and it is pretty interesting. A roundtable discussion of scientists at the leading dry-eye pharmaceuticals talking about treatment and causes of dry eye. There is quite a lot of disagreement, most of which centers upon whether inflammation or increased osmolarity comes first in dry eye.
I personally believe that increased osmolarity is essentially a synonym for dry eye. If there are less tears, of course there is going to be a higher concentration of salt in the remaining tears. I don't see how this could be a cause of dry eye. It's a symptom. It's like saying that decreased tear volume is the cause of dry eye.
Therefore, I'm more inclined to believe that inflammation disrupts the neural circuit, damages the lacrimal system, lowers tear volume and therefore increases tear osmolarity. But maybe something else is the root cause, and inflammation is just another symptom. I think it's plain to see after reading this article that we aren't quite as close to discovering the cause of DES as I had hoped we were.
I was also struck by Dr. Gilbard's incessant promotion of TheraTears products. Every other sentence he spoke mentioned them. I used TheraTears drops for several months with no noticeable improvement. In fact, I found myself needing to use the drops more and more often as time went by. But whatever, it didn't work for me, that's fine. What bothers me is that these physicians get so tied in to the success of their products that they begin to ignore other things. Of course, this problem isn't unique to DES, but I think it's more concerning in DES, since there aren't nearly as many physicians out there doing research on it as compared to say cancer or heart disease.
Okay, enough of my Sunday morning philosophizing. I'd be curious to hear what others think about this link.
Comment